COMMUNIQUÉS West-GlobeNewswire

Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer

01/07/2024 - 14:00

UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length [...]

Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

01/07/2024 - 14:00

Drug-device combination leverages Biora’s NaviCap ™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all trial objectives, [...]

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

28/06/2024 - 23:53

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Runway Growth Capital LLC is a leading U.S.-based specialty finance lender [...]

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

28/06/2024 - 23:37

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its [...]

Lowell Farms Inc. Announces Change of Chief Financial Officer

28/06/2024 - 23:30

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities including extraction, [...]

PetVivo Reports Reports Fiscal 2024 Results

28/06/2024 - 22:41

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, [...]

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

28/06/2024 - 22:39

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]

Résultats de l’Assemblée Générale Mixte de Cellectis du 28 juin 2024

28/06/2024 - 22:30

NEW YORK, 28 juin 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d’édition de génome TALEN® pour [...]

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

28/06/2024 - 22:30

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene [...]

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28/06/2024 - 22:30

BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis [...]

Information on the total number of voting rights and shares

28/06/2024 - 22:30

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 28, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]

Informations sur le nombre total de droits de vote et d'actions

28/06/2024 - 22:30

INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 28 juin 2024, 22:30 CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 [...]

GRI Bio Announces Closing of $4.0 Million Public Offering

28/06/2024 - 22:05

LA JOLLA, CA, June 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

28/06/2024 - 22:05

CHATHAM, N.J., June 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced the closing of its public [...]

NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market

28/06/2024 - 22:04

TORONTO and HAIFA, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company, is pleased to [...]

Cassava Sciences Issues Statement on Former Science Advisor

28/06/2024 - 21:58

AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the [...]

Earth Science Tech, Inc., Reports its March 31, 2024, Annual Results, Recording Over $11.9M in Revenue

28/06/2024 - 21:37

Miami, FL, June 28, 2024 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently focused on the health and wellness industry, today shares its financial results and [...]

Nipocalimab pivotal Phase 3 trial demonstrates sustained disease control in FcRn class for a broad population of myasthenia gravis patients

28/06/2024 - 18:09

First FcRn blocker to demonstrate superiority in Myasthenia Gravis - Activities of Daily Living score (MG-ADL) a over placebo when added to standard of care over 24 weeks in antibody positive patients: anti-AChR+, anti- [...]

Results of the Combined General Meeting of 28 June 2024

28/06/2024 - 17:45

Lyon (France) and Cambridge (MA, US), 28 June 2024 - 5.45 pm CEST - PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial [...]